Pharmascience Inc. is recalling one lot of prescription PMS-Ranitidine (150 mg strength tablet) as a precaution after tests found NDMA, a nitrosamine impurity, at close to the accepted level. HMC
Tag: prescription
Post
Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
Health Canada understands the stress caused by the COVID-19 pandemic and recognizes that Canadians may be concerned about not being able to get medications they rely on for themselves and their loved ones. While the Government of Canada recommends that Canadians refill their prescriptions now so that they do not have to go to a...
Post
Opioid Use
Health Canada strengthens safety information for all opioid drugs Health Canada held a Scientific Advisory Panel on Opioid Use and Contraindications, to consider whether the current contraindications for opioid use are sufficient, or whether labelling updates and other actions may be needed to reduce risks to Canadians. After thoroughly assessing the Panel’s recommendations, Health Canada is...